All posts by: Michael Zand

Immunotherapy: a new treatment paradigm in bladder cancer. – UroToday

Immunotherapy: a new treatment paradigm in bladder cancer.UroTodayT-cell checkpoint blockade has become a dynamic immunotherapy for bladder cancer. In 2016, atezolizumab, an immune checkpoint inhibitor, became the first new drug approved in metastatic … Continue reading

Immunotherapy: a new treatment paradigm in bladder cancer. – UroToday

Immunotherapy: a new treatment paradigm in bladder cancer.UroTodayT-cell checkpoint blockade has become a dynamic immunotherapy for bladder cancer. In 2016, atezolizumab, an immune checkpoint inhibitor, became the first new drug approved in metastatic … Continue reading

Orbis Research Adds a New Report Global T-Cell Immunotherapy Market 2017 Forecast – Medgadget (blog)

Orbis Research Adds a New Report Global T-Cell Immunotherapy Market 2017 Forecast Medgadget (blog) The Global T-Cell Immunotherapy market report offers a comprehensive evaluation of the Global T-Cell Immunotherapy industry. This report evaluates the Global market for “Global T-Cell Immunotherapy “. The Global T-Cell Immunotherapy market report … and more »

The Sun

Gene therapy hope for blindness NEWS.com.au On March 16, a 29-year-old man became the first patient to undergo the gene therapy procedure at Oxford Eye Hospital. The trial team hopes to recruit up to 30 patients for the study, which is designed to assess safety and tolerability rather than … NightstaRx Commences first Phase I/II Gene Therapy Clinical Trial …Yahoo Finance Brit scientists testing ‘groundbreaking’ therapy that could cure common cause of blindnessThe Sun New trial for blindness rewrites the genetic codeMedical Xpress Telegraph.co.uk –The Express Tribune –BBC News all 6 news articles »

The Sun

Gene therapy hope for blindness – The Australian The Australian A gene therapy treatment for the most common cause of blindness in young people is being tested in a group of British trial patients. Brit scientists testing ‘groundbreaking’ therapy that could cure …The Sun BBC World Service – Newsday, Hereditary blindness cure testedBBC News all 3 news articles »

The Sun

Gene therapy hope for blindness | SBS News SBS Researchers aim to use a virus to carry corrective DNA into cells at the back of the eye as a therapy for the most common cause of blindness in young people. Brit scientists testing ‘groundbreaking’ therapy that could cure …The Sun BBC World Service – Newsday, Hereditary blindness cure testedBBC News all 3 news articles »

Telegraph.co.uk

NightstaRx Commences first Phase I/II Gene Therapy Clinical Trial for Patients with X-Linked Retinitis Pigmentosa Yahoo Finance NightstaRx Ltd (“Nightstar”), a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, today announces that the Company has commenced enrolling and dosing subjects in a Phase I/II clinical trial to treat … Blind British man in world’s first operation to deliver modified DNA to his eyesTelegraph.co.uk all 2 news articles »

NightstaRx Commences first Phase I/II Gene Therapy Clinical Trial … Business Wire (press release) NightstaRx Ltd (“Nightstar”), a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, tod. and more »